As mentioned before, liposomal doxorubicin is already an approved treatment for breast cancer; albumin nanoparticulate chaperones of paclitaxel were approved for locally recurrent and metastatic breast cancer in 2005 [7,42,43]. The gene discussed is ALB; the disease is breast carcinoma.